ANNOUNCEMENT

We Are Proud to Announce Our Partnership with HitGen to Accelerate Biotechnology Discovery

Under this partnership, HitGen will provide access to its industry-leading DNA-Encoded Libraries, which contain billions of novel, drug-like small molecules, to the innovative companies at MBC BioLabs.


► READ MORE
NEWS FROM OUR RESIDENT & ALUMNI COMPANIES

Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development


► READ MORE

CuraSen’s Combination Therapy of CST-2032/CST-107 Shows Promise in Treating Cognitive Impairment in Phase 2a Trial


► READ MORE

MBC Alumni Company, Serotiny, Acquired by J&J

We’re pleased to spotlight Serotiny’s recent acquisition by Johnson & Johnson. Serotiny began operations with just a mailbox and a hot desk at the 953 Indiana MBC BioLabs site in 2020 as a JLABS company; in 2022 they began a research collaboration with J&J in order to screen multi-domain protein libraries to identify novel chimeric antigen receptor (CAR) signaling domains and moved to JLABS in South San Francisco.

With the acquisition, Serotiny will be able to further explore the potential of the company’s discovery platform. Congratulations to Colin, Justin, the entire Serotiny team, and Johnson & Johnson on the acquisition.

► READ MORE

Multiply Labs Unveils First Peer-Reviewed Study Showing that Robotic Cell Expansion Can Match the Performance and Reduce the Costs of a Manual Process


► READ MORE
UPCOMING EVENTS

Chemometec Lunch and Learn

Please join our partners at Chemometec for a lunch and learn on the NucleoCounter NC-200 located in our cores, and learn how it can help you standardize your cell counting processes.

April 9 @ noon - 1pm
930 Brittan Ave, San Carlos


► REGISTER
 

April 10 @ noon - 1pm
135 Mississippi St, San Francisco


► REGISTER

CDD’s 20th Anniversary Celebration

 

April 10 @ 9am - 5pm
National Bioskills Laboratories
435 Forbes Blvd
South San Francisco, CA 94080

Our partner, CDD, is celebrating its 20th Anniversary and will be hosting a free special user group meeting in SSF. It will be an opportunity to hear from many top-tier speakers as well as network with other professionals in the industry.

► REGISTER

ThermoFisher Lunch and Learn

Please join our partners at ThermoFisher for a lunch and learn on advancing therapies by leveraging AI tools and Machine Learning.

April 11 @ noon - 2pm
135 Mississippi St, San Francisco


► READ MORE
 

April 12 @ noon - 2pm
930 Brittan Ave, San Carlos


► READ MORE

Fireside Chat with HitGen and MBC BioLabs' Resident Companies

Learn about our newest partner, HitGen, during a fireside chat featuring Brian Moloney, CBO at HitGen, alongside two MBC residents: Sean Brown, VP of Chemistry at Dorian Therapeutics in San Carlos and Guillermo Elias, CEO at Proximity Therapeutics in San Francisco.

April 17 @ noon - 1pm
930 Brittan Ave, San Carlos


► LEARN MORE
 

April 18 @ noon - 1pm
135 Mississippi St, San Francisco


► LEARN MORE

Founders at Work: Integrated Biosciences

 

April 24 @ 12pm - 1pm
930 Brittan Ave, San Carlos

Our upcoming Founders at Work Speaker Series features Felix Wong and Max Wilson, Co-founders of Integrated Biosciences, an early-stage biotechnology company combining synthetic biology and AI to control cellular stress responses for next-generation therapeutics.

► REGISTER

Malvern Panalytical Lunch and Learn: Dynamic Light Scattering Uses

 

April 24 @ noon - 1pm
733 Industrial Rd, San Carlos

Please join our partners at Malvern Panalytical for a crash course on Dynamic Light Scattering uses in biopharmaceutical development.

► READ MORE

Revvity Spring & Science Event

 

April 25 @ 11am - 3pm
930 Brittan Ave, San Carlos

Come celebrate the beginning of the Spring season with our partners at Revvity! Learn about the LabChip GXII Touch or the Cellaca MX located in our cores over food and drinks in our outdoor patio area.

► REGISTER

TelesisBio Lunch and Learn

 

April 30 @ noon - 1pm
135 Mississippi St, San Francisco

Please join TelesisBio for a lunch and learn on the BioXp 3250 unit located in our cores!
The BioXp system can build up to 32 constructs (300 to 7k bp) in less than 21 hours, allowing you to bypass plasmid preps and synthesize transfection-ready DNA easily.

► LEARN MORE

MBC BioLabs Life Science Vendor’s Showcase May 2024

 

May 22 @ 10am - 2pm
930 Brittan Ave, San Carlos

The showcase aims to bring together the latest and greatest in life science technologies and services from a variety of vendors. This is an opportunity for our resident scientists and entrepreneurs to explore cutting-edge tools and services, learn about new techniques, resources, and network with other members of the life science community.

► REGISTER

Partner Office Hours

Connect with our partners from Malvern Panalytical, Agilent, Revvity, or Thermo Fisher Scientific during their scheduled office hours this month!

► CHECK THE CALENDAR
NEW COMPANIES

TwoStep Therapeutics

TwoStep Therapeutics is a venture-backed biotech startup leveraging proprietary tumor-targeting technology to create a pipeline of targeted cancer therapies that can deliver diverse payloads to virtually any solid tumor. TwoStep spun out from Stanford University from the labs of Jennifer Cochran, Carolyn Bertozzi, and Ron Levy, with support from the Stanford Innovative Medicines Accelerator. In March 2024, TwoStep closed its first round of funding— $6.5M seed led by NFX.

Welcome, Caitlyn Miller and Yash Agarwal of TwoStep to the 733 Industrial Road community in San Carlos! 

► READ MORE

Pioneer Research Lab

Pioneer Research Labs is engineering microbes for Mars. They are a nonprofit research organization whose goal is to design custom polyextremophiles to make Mars habitable, both indoors for bio-production and outdoors for growth. The resulting organisms will one day act as the foundation of a planetary ecosystem, and their properties will allow us to produce the first cost estimate for terraforming. 

We warmly welcome Erika Alden DeBenedictis, Seemay Chou, and Una Nattermann of the Pioneer team to our community at 135 Mississippi Street, San Francisco.

ZeptoSense

ZeptoSense believes that early detection can lead to a better outcome. ZeptoSense is developing products for the early detection of DNA/RNA/protein targets and has developed sensitive methods and workflows for genotyping and sequencing on the existing CE (Capillary Electrophoresis) and NGS platforms that can be used in cfDNA cancer detection, early infectious diseases detection, or any other low-quantity sample detection in clinical, forensics, agriculture, or biodefense applications. 

Welcome, Pero Dimsoski of ZeptoSense to the 733 Industrial Road community in San Carlos.

► READ MORE
SPECIAL THANKS TO OUR PARTNERS
MBC BioLabs - Enabling Awesome